ArticleVeterinary research communications2026
Clinical therapeutic management of camel mange: a case report.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The camel has received very little attention in contrast to other domesticated animals, especially in developing nations such as Ethiopia. As a result, camels are susceptible to several illnesses, including mange mites. In the present study, a camel whose main complaint was itching, rubs against an object and is kept extensively was treated clinically at Kombolcha City Administration Veterinary Clinic, Northeast, Ethiopia. Upon physical examination, the body temperature was 37.2 °C. The camel was emaciated, and the hair was rough. The clinical manifestations of the camel mange in the present study included hair loss on the head, with skin crust around the lower flank, hand quarters and the head and inside of the thigh and thickening and corrugation of the skin of the inguinal area, including the skin of the prepuce. The patient was clinically diagnosed with camel mange and not confirmed by laboratory diagnosis. However, therapeutic diagnosis based on three subcutaneous injections of ivermectin (1 ml/50 kg body weight) administered at ten-day intervals, together with two topical applications of amitraz applied midway between consecutive injections, this treatment was followed by the disappearance of clinical signs. Additionally, the owner was instructed to separate healthy camels from those that were contaminated, clean the fomites before and after usage, and treat the herds whenever one or more camels had clinical symptoms. There was no recurrence of infestation within five months of follow-up. Therefore, the combination of ivermectin and topical amitraz appeared effective in the clinical management of camel mange in this case. Detailed epidemiological and therapeutic investigations are warranted.
Indexed as
Identifiers
42340516What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.